Bio-Rad Laboratories Class A

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell BIO and other ETFs, options, and stocks.

About BIO

Bio-Rad Laboratories, Inc. engages in the development, manufacturing, and marketing of a portfolio of instruments, systems, reagents, and consumables. It operates through the following segments: Life Science and Clinical Diagnostics. 

CEO
Norman D. Schwartz
CEONorman D. Schwartz
Employees
7,450
Employees7,450
Headquarters
Hercules, California
HeadquartersHercules, California
Founded
1952
Founded1952
Employees
7,450
Employees7,450

BIO Key Statistics

Market cap
9.49B
Market cap9.49B
Price-Earnings ratio
42.85
Price-Earnings ratio42.85
Dividend yield
—
Dividend yield—
Average volume
221.16K
Average volume221.16K
High today
$365.16
High today$365.16
Low today
$350.77
Low today$350.77
Open price
$363.14
Open price$363.14
Volume
205.03K
Volume205.03K
52 Week high
$396.23
52 Week high$396.23
52 Week low
$236.73
52 Week low$236.73

Stock Snapshot

With a market cap of 9.49B, Bio-Rad Laboratories Class A(BIO) trades at $353.70. The stock has a price-to-earnings ratio of 42.85.

As of 2026-10-18, Bio-Rad Laboratories Class A(BIO) stock has fluctuated between $350.77 and $365.16. The current price stands at $353.70, placing the stock +0.8% above today's low and -3.1% off the high.

The Bio-Rad Laboratories Class A(BIO)'s current trading volume is 205.03K, compared to an average daily volume of 221.16K.

During the past year, Bio-Rad Laboratories Class A(BIO) stock moved between $236.73 at its lowest and $396.23 at its peak.

During the past year, Bio-Rad Laboratories Class A(BIO) stock moved between $236.73 at its lowest and $396.23 at its peak.

BIO News

Simply Wall St 1d
How Investors Are Reacting To Bio Rad Laboratories Stock Vericheck Kit Expansion

Recent market reports point to strong projected expansion in rabies diagnostics, poultry diagnostics, and digital PCR, with Bio-Rad Laboratories identified as a...

How Investors Are Reacting To Bio Rad Laboratories Stock Vericheck Kit Expansion
Simply Wall St 4d
Bio-Rad Laboratories Stock Forecast & Analyst Predictions - Simply Wall Street

...

Bio-Rad Laboratories Stock Forecast & Analyst Predictions - Simply Wall Street
Simply Wall St 4d
Is Bio Rad Laboratories Fully Priced After Rising Demand In Diagnostics And Proteomics?

Fresh industry research highlights Bio-Rad Laboratories (BIO) as a key supplier across rapid diagnostic tests, transfer membranes, and proteomics tools, with ri...

Is Bio Rad Laboratories Fully Priced After Rising Demand In Diagnostics And Proteomics?

People also own

Based on the portfolios of people who own BIO. This list is generated using Robinhood data, and it’s not a recommendation.

Similar Marketcap

This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.